These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 507226)

  • 21. Use of bethanechol chloride with phenothiazines: a case report.
    Schubert DS
    Am J Psychiatry; 1979 Jan; 136(1):110-1. PubMed ID: 758813
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversal of drug-induced priapism in a gelding by medication.
    Sharrock AG
    Aust Vet J; 1982 Jan; 58(1):39-40. PubMed ID: 7082233
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of akathisia in a severely retarded adolescent male with help of an anticholinergic drug assay.
    Harris JC; Tune LE; Allen M; Coyle JT
    Lancet; 1981 Aug; 2(8243):414. PubMed ID: 6115172
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced acute dystonic reactions in children. Alternatives to diphenhydramine therapy.
    Dahiya U; Noronha P
    Postgrad Med; 1984 Apr; 75(5):286-7, 290. PubMed ID: 6143309
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of cholinergic agents in Huntington's disease: a reappraisal.
    Nutt JG
    Neurology; 1983 Jul; 33(7):932-5. PubMed ID: 6223236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs.
    Haldeman S; Goldman JW; Hyde J; Pribram HF
    Neurology; 1981 Apr; 31(4):442-5. PubMed ID: 7194433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
    Singh MM; Kay SR
    J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the effect of certain pharmacological agents on tardive dyskinesias and the rabbit syndrome].
    Jus K; Jus A; Gautier J; Villeneuve A; Pires P; Pineau R; Villeneuve R
    Vie Med Can Fr; 1973 Sep; 2(9):871-5. PubMed ID: 4761483
    [No Abstract]   [Full Text] [Related]  

  • 30. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of phenothiazines and social skills training in a withdrawn schizophrenic.
    Hersen M; Turner SM; Edelstein BA; Pinkston SG
    J Clin Psychol; 1975 Oct; 31(4):588-94. PubMed ID: 1194410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
    Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L
    J Pediatr; 1989 Jul; 115(1):156-60. PubMed ID: 2661789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of benztropine mesylate on haloperidol-induced prolactin secretion and serum haloperidol levels in rats.
    Rosenberg JM; Sideman M; Kampa IS; McGuire H; Kampa L
    J Pharm Sci; 1984 Dec; 73(12):1833-5. PubMed ID: 6527272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 37. Medication may be required for the development of automatic information processing in schizophrenia.
    Serper MR; Bergman RL; Harvey PD
    Psychiatry Res; 1990 Jun; 32(3):281-8. PubMed ID: 2388967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial serum drug concentrations and prolonged anticholinergic toxicity after benztropine (Cogentin) overdose.
    Fahy P; Arnold P; Curry SC; Bond R
    Am J Emerg Med; 1989 Mar; 7(2):199-202. PubMed ID: 2920086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
    Baker LA; Cheng LY; Amara IB
    Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of benztropine mesylate (Cogentin) on accommodation in normal volunteers.
    Thaler JS
    Am J Optom Physiol Opt; 1982 Nov; 59(11):918-9. PubMed ID: 7180936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.